Upper-Airway Dysfunction After Prolonged Intubation: A Comprehensive Clinical Review

Abstract

Upper-airway dysfunction is a significant complication following prolonged endotracheal intubation, impacting patient recovery and quality of life. This review synthesizes current evidence regarding the prevalence, underlying mechanisms, risk factors, clinical manifestations, diagnostic approaches, management strategies, and recent advances in the field. The article aims to provide clinicians with a concise, guideline-based framework for recognizing, diagnosing, and managing upper-airway dysfunction in post-intubation patients, while highlighting gaps in current knowledge and future directions for research.

Introduction

Prolonged endotracheal intubation remains a cornerstone in the management of critically ill patients requiring mechanical ventilation. However, this life-saving intervention is associated with a spectrum of upper-airway complications that may persist well beyond extubation. Upper-airway dysfunction after prolonged intubation encompasses a range of structural and functional abnormalities, including laryngeal edema, vocal cord immobility, subglottic stenosis, and tracheal injury. Given the increasing survival of critically ill patients, recognition and management of these complications are of growing importance in modern intensive care and otolaryngology practice. This review provides a comprehensive overview of the epidemiology, pathophysiology, clinical features, diagnosis, and evidence-based management of upper-airway dysfunction following prolonged intubation, with emphasis on practical clinical implications and recent guideline recommendations.

Epidemiology / Disease Burden

The incidence of upper-airway dysfunction post-intubation varies widely, with estimates ranging from 5% to 40% depending on patient population, duration of intubation, and specific diagnostic criteria. Prolonged intubation, often defined as greater than 48–72 hours, is an established risk factor for subsequent airway complications. Laryngeal injury is seen in up to 50% of patients studied post-extubation, though only a subset manifests clinically significant dysfunction. The burden is particularly high among intensive care unit (ICU) populations, where intubation durations are frequently extended due to complex comorbidities. The clinical and economic impact is substantial, with increased length of stay, need for specialist interventions, and long-term sequelae such as voice changes, dysphagia, and airway stenosis.

Pathophysiology

Upper-airway dysfunction after prolonged intubation is primarily attributable to mechanical trauma and ischemic injury induced by the endotracheal tube. Pressure exerted by the tube and cuff leads to mucosal ulceration, perichondritis, and chondritis of the laryngeal cartilages. Subsequent inflammatory response and granulation tissue formation contribute to airway narrowing and impaired vocal cord mobility. Microbial colonization and secondary infection may exacerbate tissue damage. In some cases, fibrotic remodeling results in persistent stenosis or web formation. Additional mechanisms include direct nerve injury (notably the recurrent laryngeal nerve) and impaired mucociliary clearance, compounding the risk of dysfunction.

Risk Factors

Several modifiable and non-modifiable risk factors predispose patients to upper-airway complications following intubation. Key risk factors include prolonged duration of intubation, high endotracheal tube cuff pressures, repeated intubation attempts, oversized tubes relative to patient anatomy, traumatic intubation, and underlying comorbidities such as diabetes mellitus or connective tissue disorders. Female sex, advanced age, and pre-existing laryngeal pathology further increase susceptibility. ICU-related factors, such as sedation protocols and delayed recognition of airway injury, also play a role. Awareness of these factors is essential for risk stratification and preventive strategies.

Clinical Features

Clinical manifestations are diverse and may present acutely or subacutely after extubation. Common symptoms include hoarseness, stridor, dysphonia, throat pain, sensation of a foreign body, and dyspnea. Severe cases may progress to respiratory distress or acute airway obstruction. Laryngoscopic findings range from mild erythema and edema to vocal cord paralysis, granulation tissue, subglottic stenosis, and tracheomalacia. The onset and severity of symptoms often correlate with the duration and nature of intubation-related injury.

Diagnosis

Timely and accurate diagnosis of upper-airway dysfunction requires a high index of suspicion, particularly in high-risk populations. Flexible fiberoptic laryngoscopy is the gold standard for direct visualization of the larynx and subglottic region, allowing assessment of structural lesions, vocal cord mobility, and dynamic airway collapse. Additional modalities include videostroboscopy for detailed vocal fold evaluation, computed tomography (CT) for submucosal and extralaryngeal pathology, and pulmonary function testing for quantifying upper-airway obstruction. Diagnostic workup should be individualized based on clinical presentation and severity.

Treatment & Management

Management of upper-airway dysfunction after prolonged intubation is multifaceted, involving both medical and surgical interventions. Initial management focuses on airway stabilization and symptom relief. Systemic or inhaled corticosteroids may reduce inflammation and edema in mild cases. Nebulized epinephrine can provide temporary relief in acute airway compromise. For persistent or severe lesions, microlaryngoscopic surgery to excise granulation tissue, dilate stenotic segments, or resect webs may be required. Vocal fold immobility may necessitate medialization procedures or injection laryngoplasty. Multidisciplinary collaboration between intensivists, otolaryngologists, speech-language pathologists, and respiratory therapists is essential for optimal outcomes. Rehabilitation, including voice and swallowing therapy, plays a critical role in functional recovery.

Recent Advances / Emerging Therapies

Recent advances have focused on prevention, early detection, and minimally invasive interventions. Use of high-volume, low-pressure cuffs and subglottic suctioning endotracheal tubes has reduced the incidence of mucosal injury. Innovations in tube material and design continue to evolve. Early post-extubation laryngeal assessment is increasingly advocated, particularly in high-risk patients. Emerging therapies include topical mitomycin-C to inhibit scar formation, biodegradable stents for subglottic stenosis, and regenerative approaches targeting mucosal healing. Ongoing clinical trials are evaluating novel pharmacologic and device-based therapies aimed at modulating inflammatory response and fibrosis.

Guideline Recommendations

Current guidelines emphasize prevention through judicious patient selection for intubation, minimizing duration of intubation, regular monitoring of cuff pressures, and prompt transition to tracheostomy when prolonged ventilation is anticipated. Early recognition of symptoms and timely referral for laryngeal evaluation are key components of recommended care pathways. Management should be tailored to individual patient factors and guided by multidisciplinary input. Adherence to evidence-based protocols has been shown to improve detection, reduce complications, and enhance recovery.

Conclusion

Upper-airway dysfunction is a clinically significant and potentially preventable complication of prolonged intubation. Awareness of epidemiology, risk factors, and pathophysiology is essential for early diagnosis and effective management. Advances in preventive strategies and novel therapies hold promise for further reducing disease burden. Ongoing collaboration between critical care, otolaryngology, and rehabilitation teams remains central to optimizing patient outcomes in this challenging clinical domain.